Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L3MBTL4 antisense RNA 1 (L3MBTL4-AS1)
- Target
- L3MBTL4-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other
01
Overview
L3MBTL4 antisense RNA 1 (L3MBTL4-AS1) is a long non-coding RNA transcript that overlaps the protein-coding L3MBTL4 locus in an antisense orientation on chromosome 18. It is confirmed to lack protein-coding capacity and appears to function primarily at the RNA level, likely participating in the regulation of chromatin or transcription in cis or trans; however, there is currently no direct functional characterization or disease association published for this specific transcript. It is catalogued as a regulatory, non-coding element rather than a classic protein target.
- Other names
- NR_110765NR_110765.1lnc-ARHGAP28-4:4 (historical, previous LNCipedia version)
02
Mechanism of action
Not applicable, as there are no reported drugs targeting L3MBTL4-AS1. General mechanisms for antisense lncRNA modulation (in other contexts) include: RNA interference, Antisense oligonucleotides leading to RNase H-dependent or independent degradation, Altered chromatin accessibility.
03
Biological functions
Regulation of gene expression (primarily of the sense gene, L3MBTL4, by mechanisms such as chromatin modification or transcriptional interference)Chromatin-related regulatory functions
04
Disease associations
There is currently no direct evidence linking L3MBTL4-AS1 to a specific human disease or pathology
05
Safety considerations
None specific to L3MBTL4-AS1 reported. General concerns for lncRNA targeting include potential off-target effects and broad chromatin changes.
06
Interacting drugs
None reported for L3MBTL4-AS1
07
Biomarkers
None specifically reported for L3MBTL4-AS1. lncRNAs as a class are being explored as biomarkers, but L3MBTL4-AS1 has not been validated in this context.
Beyond the preview
Go deeper on L3MBTL4 antisense RNA 1 (L3MBTL4-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L3MBTL4 antisense RNA 1 (L3MBTL4-AS1).